HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J P Després Selected Research

Hyperinsulinism (Hyperinsulinemia)

12/2001Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity.
12/2000Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
12/2000[Risk factors associated with obesity: a metabolic perspective].
11/2000Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention study.
7/2000Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J P Després Research Topics

Disease

12Abdominal Obesity
01/2006 - 04/2000
10Coronary Disease (Coronary Heart Disease)
09/2003 - 02/2000
9Weight Loss (Weight Reduction)
11/2015 - 10/2000
8Obesity
11/2015 - 03/2000
8Cardiovascular Diseases (Cardiovascular Disease)
04/2011 - 02/2000
7Type 2 Diabetes Mellitus (MODY)
03/2015 - 06/2000
7Hypertriglyceridemia
07/2007 - 01/2000
7Insulin Resistance
08/2006 - 12/2000
6Body Weight (Weight, Body)
11/2015 - 06/2000
6Glucose Intolerance
03/2015 - 05/2000
6Dyslipidemias (Dyslipidemia)
12/2001 - 06/2000
5Myocardial Ischemia (Ischemic Heart Diseases)
12/2001 - 12/2000
5Hyperinsulinism (Hyperinsulinemia)
12/2001 - 07/2000
3Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2006 - 12/2001
3Overweight
08/2006 - 08/2001
2Pathologic Constriction (Stenosis)
01/2011 - 06/2009
2Atherosclerosis
12/2001 - 04/2000
2Hyperlipidemias (Hyperlipidemia)
12/2000 - 12/2000
1Hypoadiponectinemia
01/2011
1Inflammation (Inflammations)
06/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2001
1Hypercholesterolemia
12/2001
1Hemolysis
08/2001
1Hypoalphalipoproteinemias (Hypoalphalipoproteinemia)
07/2001
1Myocardial Infarction
12/2000
1Hypertriglyceridemic Waist
07/2000
1Hypertrophy
06/2000

Drug/Important Bio-Agent (IBA)

14HDL CholesterolIBA
08/2006 - 04/2000
13oxidized low density lipoproteinIBA
04/2011 - 01/2000
9LipidsIBA
06/2009 - 08/2000
8Insulin (Novolin)FDA Link
09/2003 - 02/2000
7Triglycerides (Triacylglycerol)IBA
08/2006 - 06/2000
6ApolipoproteinsIBA
07/2007 - 12/2000
5Glucose (Dextrose)FDA LinkGeneric
03/2015 - 09/2000
4Lipoprotein Lipase (Diacylglycerol Lipase)IBA
09/2013 - 06/2000
4LDL CholesterolIBA
12/2001 - 12/2000
4LDL Lipoproteins (beta Lipoproteins)IBA
11/2001 - 12/2000
4HDL LipoproteinsIBA
07/2001 - 08/2000
4Lipoproteins (Lipoprotein)IBA
06/2001 - 08/2000
4Apolipoproteins B (ApoB)IBA
12/2000 - 01/2000
3LeptinIBA
10/2001 - 06/2000
2Sterol Esterase (Hormone-Sensitive Lipase)IBA
09/2013 - 06/2000
2Adrenergic Receptors (Adrenergic Receptor)IBA
09/2013 - 09/2001
2AdiponectinIBA
01/2011 - 08/2006
2EndocannabinoidsIBA
08/2006 - 01/2006
2RimonabantIBA
08/2006 - 01/2006
2Metformin (Glucophage)FDA LinkGeneric
08/2006 - 09/2003
2CholesterolIBA
12/2001 - 11/2001
2C-Reactive ProteinIBA
11/2001 - 06/2001
2Polychlorinated Biphenyls (PCBs)IBA
11/2001 - 10/2000
2Environmental Pollutants (Pollutants, Environmental)IBA
11/2001 - 10/2000
2Glycerol (Glycerine)FDA LinkGeneric
03/2001 - 05/2000
2SteroidsIBA
11/2000 - 03/2000
2Estrogens (Estrogen)FDA Link
11/2000 - 02/2000
2Hormones (Hormone)IBA
03/2000 - 02/2000
1hydroxide ionIBA
11/2015
125-hydroxyvitamin DIBA
11/2015
1Vitamin DFDA LinkGeneric
11/2015
1Lipase (Acid Lipase)FDA Link
09/2013
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2006
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2006
1ElementsIBA
09/2003
1Dehydroepiandrosterone (DHEA)IBA
03/2003
1Fibric Acids (Fibrates)IBA
12/2001
1Fenofibrate (CiL)FDA LinkGeneric
12/2001
1Dichlorodiphenyl Dichloroethylene (DDE)IBA
11/2001
1antineoplaston A10 (A 10)IBA
11/2001
1Fatty Acid-Binding ProteinsIBA
11/2001
1aroclor 1260IBA
11/2001
1Hexachlorobenzene (HCB)IBA
11/2001
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
09/2001
1Gemfibrozil (Lopid)FDA LinkGeneric
08/2001
1NitrogenIBA
08/2001
1Pharmaceutical PreparationsIBA
06/2001
1Nonesterified Fatty Acids (NEFA)IBA
03/2001
1Apolipoprotein B-48IBA
12/2000
1VLDL LipoproteinsIBA
12/2000
1Dietary Fats (Dietary Fat)IBA
12/2000
1Chylomicron RemnantsIBA
12/2000
1Sex Hormone-Binding GlobulinIBA
11/2000
1AndrogensIBA
11/2000
1Gonadal Steroid Hormones (Sex Hormones)IBA
11/2000
1Chlorinated HydrocarbonsIBA
10/2000
1low density lipoprotein inhibitorIBA
07/2000
1PPAR alphaIBA
06/2000
1Azathioprine (Imuran)FDA LinkGeneric
04/2000
1Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2000
1Cholesterol Ester Transfer ProteinsIBA
04/2000
1Prednisone (Sone)FDA LinkGeneric
04/2000
1lipoprotein cholesterolIBA
01/2000

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2006 - 12/2000
2Therapeutics
01/2006 - 12/2001
1Preoperative Period
01/2011
1Bioprosthesis
06/2009
1Secondary Prevention
12/2000
1Kidney Transplantation
04/2000